CM
ABBV icon

Columbus Macro’s AbbVie ABBV Stock Holding History

Columbus Macro’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.76M Buy
30,821
+572
+2% +$123K 0.75% 50
2026
Q1 		$6.58M Buy
30,249
+971
+3% +$215K 0.7% 56
2025
Q4 		$6.69M Buy
29,278
+252
+0.9% +$57.4K 0.73% 54
2025
Q3 		$6.72M Buy
29,026
+1,203
+4% +$245K 0.77% 55
2025
Q2 		$5.16M Buy
27,823
+1,711
+7% +$318K 0.63% 69
2025
Q1 		$5.47M Sell
26,112
-16,769
-39% -$3.26M 0.72% 53
2024
Q4 		$7.62M Buy
42,881
+29,524
+221% +$5.43M 1.06% 21
2024
Q3 		$2.63M Sell
13,357
-481
-3% -$89.8K 0.96% 24
2024
Q2 		$2.35M Sell
13,838
-357
-3% -$59.1K 0.91% 27
2024
Q1 		$2.58M Sell
14,195
-1,060
-7% -$183K 0.98% 22
2023
Q4 		$2.4M Sell
15,255
-104
-0.7% -$15.2K 0.95% 26
2023
Q3 		$2.29M Sell
15,359
-542
-3% -$79.6K 0.97% 26
2023
Q2 		$2.16M Buy
15,901
+837
+6% +$123K 0.86% 34
2023
Q1 		$2.41M Buy
15,064
+91
+0.6% +$13.9K 0.9% 35
2022
Q4 		$2.42M Sell
14,973
-153
-1% -$23.5K 0.93% 32
2022
Q3 		$2.03M Sell
15,126
-338
-2% -$48.5K 0.83% 35
2022
Q2 		$2.37M Buy
15,464
+2,844
+23% +$435K 0.9% 32
2022
Q1 		$2.05M Buy
12,620
+498
+4% +$72.3K 0.7% 44
2021
Q4 		$1.64M Buy
12,122
+9,811
+425% +$1.16M 0.55% 56
2021
Q3 		$249K Sell
2,311
-26
-1% -$2.97K 0.08% 149
2021
Q2 		$263K Sell
2,337
-30
-1% -$3.38K 0.08% 153
2021
Q1 		$256K Sell
2,367
-587
-20% -$62.8K 0.08% 159
2020
Q4 		$317K Sell
2,954
-383
-11% -$36.8K 0.1% 136
2020
Q3 		$292K Sell
3,337
-2,533
-43% -$238K 0.09% 132
2020
Q2 		$576K Sell
5,870
-2,267
-28% -$200K 0.16% 85
2020
Q1 		$620K Sell
8,137
-2,246
-22% -$191K 0.18% 98
2019
Q4 		$919K Buy
10,383
+3,191
+44% +$265K 0.2% 87
2019
Q3 		$545K Sell
7,192
-1,505
-17% -$103K 0.14% 95
2019
Q2 		$632K Buy
8,697
+3,391
+64% +$267K 0.14% 96
2019
Q1 		$428K Sell
5,306
-57
-1% -$4.66K 0.09% 115
2018
Q4 		$494K Sell
5,363
-199
-4% -$17.5K 0.11% 107
2018
Q3 		$526K Buy
5,562
+268
+5% +$25.4K 0.13% 106
2018
Q2 		$490K Sell
5,294
-156
-3% -$15.2K 0.13% 104
2018
Q1 		$516K Sell
5,450
-1,064
-16% -$117K 0.13% 87
2017
Q4 		$630K Buy
+6,514
New +$614K 0.2% 69

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Columbus Macro's ABBV Position: Q2 2026 in Review

Columbus Macro increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $123K and bringing the position to 30,821 shares worth $7.76M. The position accounts for 0.75% of the portfolio, ranked #50.

Columbus Macro first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Columbus Macro held 30,821 shares of AbbVie worth $7.76M as of Q2 2026.
  • Columbus Macro bought 572 AbbVie shares in Q2 2026, an estimated $123K.
  • AbbVie made up 0.75% of Columbus Macro's portfolio in Q2 2026, its #50 holding.
  • Columbus Macro first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Columbus Macro's 13F filing for Q2 2026, filed 22 Jul 2026.